Bioinformatic analyses reveal lysosomal-associated protein transmembrane 5 as a potential therapeutic target in lipotoxicity-induced injury in diabetic kidney disease

Xin Chen Shenglong Zhu Ciyou Huang Jiayi Liu Jinbang Wang Siyuan Cui a Department of Endocrinology,Jiangnan University Medical Center,Affiliated Wuxi Clinical College of Nantong University,Wuxi No.2 People's Hospital,Wuxi,P. R. Chinab School of Medicine,Nanjing Medical University,Nanjing,P. R. Chinac Wuxi School of Medicine,Jiangnan University,Wuxi,P. R. Chinad Subei People's Hospital of Jiangsu Province,Clinical Medical School of Yangzhou University,Yangzhou,Jiangsu,P. R. China
DOI: https://doi.org/10.1080/0886022x.2024.2359638
IF: 3.222
2024-06-05
Renal Failure
Abstract:Emerging data have revealed that damage to tubular epithelial cell is a driving force in the progression of diabetic kidney disease (DKD). However, the specific mechanisms by which lipotoxicity contributes to the injury of these cells, thereby influencing the development of DKD, are yet to be fully understood. Here, we analyzed the GSE 30529 microarray datasets of human tubulointerstitial tissue samples from the Gene Expression Omnibus database (GEO). Concurrently, we conducted RNA-sequencing on palmitic acid (PA)-treated human renal proximal tubule epithelial cells (HK2 cells). After normalization, the differentially expressed genes (DEGs) were screened by R software and gene ontology (GO) enrichment analysis was conducted, and lysosomal-associated protein transmembrane 5 (LAPTM5) was finally selected. Our findings indicate that the expression of LAPTM5 was obviously increased in DKD patients, and the correlation between LAPTM5, and other clinical parameters of DKD was analyzed using the Spearman correlation analysis. The potential of LAPTM5 as a prognostic biomarker for DKD was further consolidated through receiver operating characteristic (ROC) analysis. To further verify the function of LAPTM5, we established mouse or in vitro systems mimicking DKD. The results showed that a consistent upregulation of LAPTM5, which was also found to be linked with inflammatory mediators within the context of DKD. Additionally, LAPTM5 silencing significantly downregulated mRNA expression of inflammatory factors in PA-treated HK2 cells. These results indicate that LAPTM5 is a potential biomarker and therapeutic treatment target for DKD. This discovery paves the way for future research and development of targeted interventions aimed at mitigating the progression of this prevalent condition.
urology & nephrology
What problem does this paper attempt to address?
The paper aims to explore the mechanisms of tubular epithelial cell injury in lipotoxicity-induced diabetic kidney disease (DKD) and to identify potential therapeutic targets. Specifically, the study reveals the role of lysosomal-associated transmembrane protein 5 (LAPTM5) in lipotoxicity-induced DKD through bioinformatics analysis, suggesting that LAPTM5 may be a potential diagnostic marker and therapeutic target for DKD. The main findings of the paper include: 1. **Upregulation of LAPTM5 expression**: Analysis of microarray data and RNA sequencing data revealed that LAPTM5 expression is significantly upregulated in DKD patients and PA-treated HK-2 cells. 2. **Association with inflammatory factors**: The expression of LAPTM5 is positively correlated with various inflammatory factors (such as IL-1β, IL-6, and TNF-α), suggesting its involvement in the inflammatory response. 3. **Diagnostic value**: Through ROC curve analysis, LAPTM5 was found to have high diagnostic value and could serve as a potential biomarker for DKD. 4. **In vivo validation**: The expression of LAPTM5 and its correlation with inflammatory factors were further validated in db/db mice and high-fat diet plus streptozotocin (HFD-STZ)-induced DKD mouse models. 5. **Knockdown experiments**: After siRNA knockdown of LAPTM5, the expression of inflammatory factors was significantly reduced, suggesting that LAPTM5 may be an important pro-inflammatory gene and is related to lipid metabolism. These results not only deepen the understanding of the molecular mechanisms of DKD but also provide potential targets for developing new therapeutic strategies.